The primary mission for The Division of Surgical Oncology at the University of Minnesota is to provide state-of-the-art care for cancer patients.
Our surgeons evaluate and treat patients with a variety of benign and malignant diseases. Our board-certified surgeons all have specialized fellowship training and work in a multidisciplinary setting with other specialists to provide the latest treatments and innovations in surgical cancer care.
The Division is at the forefront of new research and technology for cancer patients. Our patients are offered the opportunity to participate in clinical research trials through the only National Cancer Institute-Designated Comprehensive Cancer Center in the Twin Cities.
Conditions we treat
Our surgeons treat a variety of diseases including:
- Breast cancer
- Pancreas cancer
- Liver tumors
- Gallbladder/bile duct tumors
- Thyroid and parathyroid disease
- Adrenal tumors
- Stomach cancer
- Appendix cancer
- Metastatic colorectal cancer
The faculty members not only perform advanced procedures, they also create innovative treatments for cancer patients.
Specialized cancer treatments include laparoscopic pancreas and liver resections, sentinel lymph node biopsy, skin- and nipple-sparing mastectomy, isolated limb infusion, radiofrequency ablation, laparoscopic adrenalectomy, robotic thyroidectomy, hyperthermic intraperitoneal chemotherapy, and videoscopic femoral lymph node dissections.
Dr. Tuttle discusses a recent study regarding double mastectomies in men facing breast cancer
Even among men who have a BRCA1 or BRCA2 mutation, there has not been enough research looking at whether a double mastectomy can improve life expectancy, said Dr. Todd M. Tuttle, chief of surgical oncology at the University of Minnesota. Tuttle was involved in a study that found little benefit of a double mastectomy for women without genetic risk factors, but he did not participate in the current research.